In addition, DC numbers were not associated with tumor stage, histology, or smoking history and we could not establish any association between the number of infiltrating CD1a+ or CD83+ DCs and overall survival of NSCLC patients. The gene discussed is CD83; the disease is non-small cell lung carcinoma.